The frequent continuation of other diabetes medications while initiating insulin therapy underscores the need for further research into diabetes treatment during the insulin transition to inform evidence-based guidelines that promote optimal management during this critical transition in care. The gene discussed is INS; the disease is diabetes mellitus.